The most important financial indicators for the company Inter Pharma Company Srl - Unique Identification Number 17787251:
sales in 2023 was
229.263
euro, registering a net profit of
13.093
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor cosmetice si de parfumerie having the NACE code 4645.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
Inter Pharma Company Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
45.660
60.197
80.125
85.342
93.035
134.311
114.811
133.255
186.516
229.263
Total Income - EUR
44.048
60.141
80.258
88.188
93.838
135.235
115.054
133.840
187.792
229.273
Total Expenses - EUR
38.270
58.278
83.366
85.580
92.304
130.661
111.338
127.666
185.203
214.159
Gross Profit/Loss - EUR
5.778
1.862
-3.108
2.608
1.534
4.574
3.716
6.174
2.589
15.114
Net Profit/Loss - EUR
4.459
66
-4.706
1.425
601
3.233
2.655
4.998
1.008
13.093
Employees
1
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 23.3%, from 186.516 euro in the year 2022, to 229.263 euro in 2023.
The Net Profit increased by 12.089 euro, from 1.008 euro in 2022, to 13.093 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Inter Pharma Company Srl - CUI 17787251
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
1.657
632
0
0
22.818
40.780
31.714
22.903
14.840
10.075
Current Assets
46.534
58.575
57.144
40.310
52.222
45.762
42.054
49.456
51.377
71.924
Inventories
37.451
22.244
24.987
15.838
28.406
26.439
22.450
24.598
20.065
37.967
Receivables
8.070
35.928
26.529
23.428
16.870
16.926
17.925
16.966
28.508
21.245
Cash
1.013
404
5.628
1.044
6.946
2.397
1.679
7.893
2.805
12.712
Shareholders Funds
-1.561
-1.508
-6.199
-4.670
-3.982
-672
1.996
6.949
7.979
21.048
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
49.991
60.718
63.359
45.001
79.503
87.843
72.187
65.973
58.962
61.217
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4645 - 4645"
CAEN Financial Year
4645
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
71.924 euro in 2023 which includes Inventories of
37.967 euro, Receivables of
21.245 euro and cash availability of
12.712 euro.
The company's Equity was valued at
21.048 euro, while total Liabilities amounted to
61.217 euro.
Equity increased by 13.093 euro, from 7.979 euro in 2022, to 21.048 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Inter Pharma Company Srl